【结 构 式】 |
【药物名称】 【化学名称】N-(4,5-Dihydro-1H-imidazol-2-ylmethyl)-N-[5-methoxy-2-(methylsulfonyl)phenyl]amine fumarate 【CA登记号】305809-61-4, 305809-60-3 (free base) 【 分 子 式 】C16H21N3O7S 【 分 子 量 】399.42567 |
【开发单位】GlaxoSmithKline (Originator) 【药理作用】RENAL-UROLOGIC DRUGS, Urinary Incontinence Therapy, alpha1A-Adrenoceptor Agonists |
合成路线1
5-Methoxy-2-methylbenzothiazole (I) is hydrolyzed by NaOH in ethylene glycol to furnish 2-amino-4-methoxythiophenol (II), which is further alkylated with iodomethane and potassium tert-butoxide, yielding thioether (III). Condensation of aniline (III) with 2-(chloromethyl)imidazoline (IV) in the presence of phenol provides (V). After oxidation of sulfide (V) to the corresponding sulfone by means of m-chloroperbenzoic acid, the title compound is isolated as its fumarate salt (1,2).
【1】 Hodson, S.J.; Bishop, M.J.; Speake, J.D.; Navas, F. III; Garrison, D.T.; Bigham, E.C.; Saussy, D.L. Jr.; Liacos, J.A.; Irving, P. E.; Gobel, M.J.; Sherman, B.W.; 2-(Anilinomethyl)imidazolines as alpha1 adrenergic receptor agonists: The discovery of alpha1a subtype selective 2'-alkylsulfonyl-substituted analogues. J Med Chem 2002, 45, 11, 2229. |
【2】 Hodson, S.J.; Navas, F. III; Bishop, M.J.; Bigham, E.C.; Garrison, D.T.; Drewry, D.H.; Speake, J.D. (Glaxo Group Ltd.); Imidazoline derivs. as alpha-1A adrenoceptor ligands. WO 0066563 . |
中间体序号 | 中间体编号 | 品名 | CAS号 | 分子式 | 供应商 | 用于合成 |
---|---|---|---|---|---|---|
(I) | 63668 | 5-methoxy-2-methyl-1,3-benzothiazole; methyl 2-methyl-1,3-benzothiazol-5-yl ether | C9H9NOS | 详情 | 详情 | |
(II) | 63669 | 2-amino-4-methoxybenzenethiol; 2-amino-4-methoxyphenylhydrosulfide | C7H9NOS | 详情 | 详情 | |
(III) | 63670 | 5-methoxy-2-(methylsulfanyl)aniline; 5-methoxy-2-(methylsulfanyl)phenylamine | C8H11NOS | 详情 | 详情 | |
(IV) | 17330 | 2-(chloromethyl)-4,5-dihydro-1H-imidazole | C4H7ClN2 | 详情 | 详情 | |
(V) | 63671 | N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-5-methoxy-2-(methylsulfanyl)aniline; N-(4,5-dihydro-1H-imidazol-2-ylmethyl)-N-[5-methoxy-2-(methylsulfanyl)phenyl]amine | C12H17N3OS | 详情 | 详情 |